1. Home
  2. MPU vs ELUT Comparison

MPU vs ELUT Comparison

Compare MPU & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MPU

Mega Matrix Corp.

N/A

Current Price

$0.85

Market Cap

57.6M

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.09

Market Cap

46.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPU
ELUT
Founded
1989
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Transportation Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.6M
46.5M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
MPU
ELUT
Price
$0.85
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
55.8K
171.3K
Earning Date
03-09-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
0.87
Revenue
N/A
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
N/A
$1.22
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.50
52 Week High
$4.44
$2.99

Technical Indicators

Market Signals
Indicator
MPU
ELUT
Relative Strength Index (RSI) 47.14 51.40
Support Level $0.77 $0.89
Resistance Level $1.00 $1.15
Average True Range (ATR) 0.06 0.13
MACD -0.00 -0.02
Stochastic Oscillator 54.73 26.25

Price Performance

Historical Comparison
MPU
ELUT

About MPU Mega Matrix Corp.

Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: